According to a report by The Brainy Insights, the global capsule endoscopy market was valued at USD 680 million in 2022 and is projected to reach USD 1,500.58 million by 2030, growing at a compound annual growth rate (CAGR) of 10.40% during the forecast period from 2022 to 2030.
Market Introduction: Capsule endoscopy is a medical procedure that enables physicians to examine the entire gastrointestinal tract using a swallowable capsule equipped with a camera. As the capsule traverses the digestive system, it captures images and transmits them wirelessly to a recorder. This minimally invasive technique offers a comprehensive view of the intestines, aiding in the diagnosis of conditions such as obscure gastrointestinal bleeding, Crohn’s disease, and small intestine tumors.
Recent Developments:
-
December 2022: AnX Robotica Corporation announced a collaboration with GastroGPO to promote the adoption of the NaviCam® Magnetically Controlled Capsule Endoscopy System (MCCE). This system allows for a minimally invasive, sedation-free diagnostic procedure to visualize the stomach and esophagus, enhancing clinical decision-making.
-
March 2022: Scottish health researchers initiated a USD 6.4 million project to integrate AI-assisted capsule endoscopy into bowel cancer diagnostics. This initiative aims to utilize “smart pills” equipped with cameras to capture images of the intestines, facilitating early detection and diagnosis of bowel cancer.
Drivers:
- Increasing Prevalence of Gastrointestinal Disorders: The rising incidence of gastrointestinal diseases, particularly among the aging population, is a significant driver for the capsule endoscopy market. Unhealthy lifestyles, poor dietary habits, and stress contribute to the growing number of gastrointestinal issues, necessitating effective diagnostic tools like capsule endoscopy.
Restraints:
- Medical Risks Associated with Capsule Endoscopy: While generally safe, capsule endoscopy carries potential risks such as capsule retention, tissue tearing, or internal bleeding. These complications may deter some patients from opting for this procedure. Additionally, the high cost of the procedure, coupled with limited reimbursement policies in low- and middle-income countries, can hinder market growth.
Opportunities:
- Technological Advancements: The integration of artificial intelligence, machine learning, and robotics into capsule endoscopy procedures presents significant growth opportunities. These advancements aim to enhance the safety, precision, and accuracy of the procedure, leading to improved patient outcomes. Ongoing research and development efforts, supported by increased funding, are expected to drive innovation in this field.
Looking for sample report, click here @ https://www.thebrainyinsights.com/enquiry/sample-request/13275
Regional Segmentation Analysis:
- North America: In 2022, North America dominated the capsule endoscopy market, accounting for 47.21% of the market share. This dominance is attributed to advanced healthcare infrastructure, favorable reimbursement policies, and a high prevalence of gastrointestinal disorders. The presence of major industry players and a focus on early disease detection further contribute to the region’s leading position.
The capsule endoscopy market is poised for significant growth, driven by technological advancements and an increasing prevalence of gastrointestinal disorders globally.